Colorectal Cancer Screening Program
Screening Methods
Fecal Occult Blood Test (FOBT) – Detects microscopic blood traces invisible to the naked eye.
Colonoscopy (recommended if FOBT is positive) – Direct visualization and intervention.
Program Features
Non-invasive Screening: FOBT offers a simple first-step detection method.
Cancer Prevention Focus: Removal of colorectal polyps during colonoscopy prevents cancerous transformation.
Early Intervention: Identifies high-risk individuals or early-stage lesions, enabling timely treatment and improved outcomes.
Enhanced Survival Rates: Early intervention enhances treatment success rates and long-term prognosis.
Individuals with a history of colorectal cancer – Prioritize recurrence monitoring.
Chronic inflammatory bowel disease (e.g., ulcerative colitis, Crohn’s disease) – Long-term inflammation elevates cancer risk.
Confirmed hereditary intestinal disorders (e.g., Lynch syndrome) or first-degree relatives with such conditions – Genetic predisposition screening.
Two or more first-degree relatives diagnosed with colorectal cancer – Hereditary risk assessment.
History of colorectal polyps (adenomatous type) with current symptoms – Timely intervention for precancerous lesions.
Individuals medically ineligible for colonoscopy requiring alternative screening.
Colonoscopy within the past 10 years (with physician-recommended follow-up).
Fecal occult blood test (FOBT) within the past 2 years (requires retesting if positive).